-

Mevion Medical Systems Appoints Curt Kienast as Chief Operating Officer

original Curt Kienast, Chief Operating Officer (Photo: Business Wire)

Curt Kienast, Chief Operating Officer (Photo: Business Wire)

LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems, the leader in compact proton therapy, today announced the appointment of Curt Kienast to chief operating officer of the organization, effective immediately. In this role, Kienast is responsible for leading the company’s end to end processes, scaling development, and amplifying operational excellence.

“I am very proud to announce the promotion of Curt to chief operating officer,” said Tina Yu, chief executive officer of Mevion Medical Systems. “Curt is a 13-year Mevion veteran, and his passion has proved to be vital to our organization, and as we evolve, he will be a leader who can propel our strengths and our expansion.”

Proton therapy is a more precise therapeutic radiation to the tumor and less damaging to nearby organs and is becoming a favored tool among top centers around the world. Mevion provides the most compact and precise proton systems available today and has been selected by leading clinical centers in the U.S., Europe, and China.

Kienast was previously vice president of global service. He has held many cross-functional roles during his tenure, including leadership roles in quality assurance, engineering, and service. Kienast’s innovative approaches to customer service and lean manufacturing have been instrumental in the company’s continued growth and success.

“I am honored and excited for the opportunity to lead Mevion’s team in a greater capacity,” said Curt Kienast. “Mevion has secured a distinctive position in the global market, and my goal is to ensure we maintain our competitive edge, our culture of customer service, and build on our teams’ unified focus to drive us into the future.”

About Mevion Medical Systems

Mevion Medical Systems, Inc. is the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients. Mevion is based in Littleton, Massachusetts, with a presence in Europe and Asia. For more information, please visit www.mevion.com.

Follow us on Twitter: @MevionMedical
Connect with us on LinkedIn: Mevion Medical Systems
Like Us on Facebook: MevionMedical

Contacts

Melanie Benton
Mevion Medical Systems
Mbenton@mevion.com 1-978-540-1551

Industry:

Mevion Medical Systems, Inc.

Release Versions
English
Hashtags
#cancercare
#cancertreatment
#mevion
#protontherapy

Contacts

Melanie Benton
Mevion Medical Systems
Mbenton@mevion.com 1-978-540-1551

Social Media Profiles
Mevion Medical Systems on Facebook
Mevion Medical Systems on Instagram
Mevion Medical Systems on LinkedIn
Mevion Medical Systems on Twitter
More News From Mevion Medical Systems, Inc.

Carilion Clinic and Mevion Medical Systems Announce Plans to Bring Proton Therapy to Southwest Virginia

ROANOKE, Va. & LITTLETON, Mass.--(BUSINESS WIRE)--Carilion Clinic, a leading integrated health system serving western Virginia, and Mevion Medical Systems, the global leader in compact proton therapy, today announced a partnership to bring advanced proton therapy to the new Carilion Taubman Cancer Center, now under construction in Roanoke. A Regional Milestone in Cancer Care The new Carilion Taubman Cancer Center will transform how cancer care is delivered across Southwest Virginia, bringing to...

Loma Linda University Health, Pioneer of Hospital-Based Proton Therapy, Selects Mevion FIT System to Launch Next Era of Cancer Care

LOMA LINDA, Calif. & LITTLETON, Mass.--(BUSINESS WIRE)--Loma Linda University Health (LLUH), the institution that created the world's first hospital-based Proton Therapy Treatment Center in 1990, and Mevion Medical Systems, the leading provider of compact proton therapy solutions, today announced a historic partnership to install the MEVION S250-FIT Proton Therapy System™. This milestone represents both a clinical leap forward and a symbolic return to the front lines of innovation for LLUH, lau...

Mevion Medical Systems Announces FDA Clearance for MEVION S250-FIT™ Proton Therapy System

LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the MEVION S250-FIT™ Proton Beam Radiation Therapy System, marking a significant milestone in expanding access to proton therapy.  The MEVION S250-FIT is the first and only proton therapy system designed to seamlessly fit into a standard radiation therapy vault. By leveraging existing infrastructure, the MEVION S250-FIT system lowers barrier...
Back to Newsroom